FindTrial
Sign In

Bilva Patra Kwath Sitz Bath in the management of Abhyantar Arsha(Internal Haemorrhoids).

A Randomised Comparative Clinical trial to evaluate the efficacy of Bilva Patra Kwath Avagaha Swedan & Gud-Haritaki compared with Alum-Turmeric Sitz bath & Gud-Haritaki in the management of Abhyantar Arsha. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103913
Enrollment
30
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre,Nigdi,Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having Abhyantar Arsha 1 ,2 ,3 . With any 2 of 4 symptoms 1.Gudakandu 2.Gudagat Raktastrav 3.Vibandha 4.Gudashula Patients aged 19-60 years,Irrespective of gender,cast,religion,economic status.

Exclusion criteria

Exclusion criteria: Associated with other Ano-rectal conditions as following: 1.Fistula-in-Ano 2.Prolapse of rectum 3.Perianal abscess 4.Malignancy 5.Thrombosed Piles 6.4 Piles Major Cardiac Illness. Known case of Diabetes Mellitus.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy between Bilva Patra Kwath Avagaha Swedan and Gud-Haritaki with Alum-Turmeric Sitz bath and Gud-Haritaki in the management of Abhyantar Arsha. Assessment will be done by criteria like Reduction in 1.Pile Mass. 2.Gudakandu. 3.Gudagat Raktasrav. 4.Vibhandh. 5.Gudshula.Timepoint: Patient will be followed up on 7th,14th,21th Day.—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Kiran Mendhekar

PDEAs College of Ayurved and Research Centre,Nigdi,Pune

doctor.kiran.mendhekar@gmail.com9867802319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026